Peter J Wild
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Jörger M, Alonso G, Goebeler M, Schuler M, König D, Dummer R, Reig M, Rodriguez Ruiz M, Calvo E, Esteban-Villarrubia J, Oberoi A, Sabat P, Soto-Castillo J, Koster K, Saavedra O, Sayehli C, Gromke T, Läubli H, Ramelyte E, Fortuny M, Landa-Magdalena A, Moreno I, Torres-Jiménez J, Hernando-Calvo A, Hess D, Racca F, Richly H, Schmitt A, Eggenschwiler C, Sanduzzi-Zamparelli M, Vilalta-Lacarra A, Trojan J, Koch C, Galle P, Foerster F, Trajanoski Z, Hackl H, Gogolla F, Koll F, Wild P, Chun F, Reis H, Lloyd P, Machacek M, Gajewski T, Fridman W, Eggermont A, Bargou R, Schöniger S, Rüschoff J, Tereshchenko A, Zink C, Dantas-Silva A, Lichtenegger F, Akdemir J, Rüdiger M, L'Huillier P, Dutta A, Haake M, Auckenthaler A, Gjorgjioska A, Rössler B, Hermann F, Liebig M, Reichhardt D, Schuberth-Wagner C, Wischhusen J, Fettes P, Auer M, Klar K, Leo E. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature 2024
11.12.2024Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
11.12.2024Nature 2024
Melero Ignacio, de Miguel Luken Maria, de Velasco Guillermo, Garralda Elena, Martin-Liberal Juan, Jörger Markus, Alonso Guzman, Goebeler Maria-Elisabeth, Schuler Martin, König David, Dummer Reinhard, Reig Maria, Rodriguez Ruiz Maria-Esperanza, Calvo Emiliano, Esteban-Villarrubia Jorge, Oberoi Arjun, Sabat Paula, Soto-Castillo Juan José, Koster Kira-Lee, Saavedra Omar, Sayehli Cyrus Michael, Gromke Tanja, Läubli Heinz, Ramelyte Egle, Fortuny Marta, Landa-Magdalena Ana, Moreno Irene, Torres-Jiménez Javier, Hernando-Calvo Alberto, Hess Dagmar, Racca Fabricio, Richly Heike, Schmitt Andreas Michael, Eggenschwiler Corinne, Sanduzzi-Zamparelli Marco, Vilalta-Lacarra Anna, Trojan Jörg, Koch Christine, Galle Peter R, Foerster Friedrich, Trajanoski Zlatko, Hackl Hubert, Gogolla Falk, Koll Florestan J, Wild Peter J, Chun Felix Kyoung Hwan, Reis Henning, Lloyd Peter, Machacek Matthias, Gajewski Thomas F, Fridman Wolf H, Eggermont Alexander M M, Bargou Ralf C, Schöniger Sandra, Rüschoff Josef, Tereshchenko Anastasiia, Zink Carina, Dantas-Silva Amanda, Lichtenegger Felix S, Akdemir Julia, Rüdiger Manfred, L'Huillier Phil, Dutta Aradhana, Haake Markus, Auckenthaler Alexandra, Gjorgjioska Ana, Rössler Bernhard, Hermann Frank, Liebig Mara, Reichhardt Daniela, Schuberth-Wagner Christine, Wischhusen Jörg, Fettes Petra, Auer Marlene, Klar Kathrin, Leo Eugen
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
Britschgi C, Banna G, Wild P, Rothschild S, Gautschi O, Banini M, Metro G, Früh M, Delaloye R, Rechsteiner M, Addeo A, Curioni-Fontecedro A. Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients. Front Oncol 2020; 10:1299.
21.08.2020Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
21.08.2020Front Oncol 2020; 10:1299
Britschgi Christian, Banna Giuseppe L, Wild Peter J, Rothschild Sacha I, Gautschi Oliver, Banini Marco, Metro Giulio, Früh Martin, Delaloye Raphaël, Rechsteiner Markus, Addeo Alfredo, Curioni-Fontecedro Alessandra
High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification
Zhu Y, Christiansen A, Fritz C, Rupp N, Poyet C, Rushing E, Weller M, Roth P, Haralambieva E, Hofer S, Chen C, Jochum W, Gao X, Teng X, Chen L, Zhong Q, Wild P, Aebersold R, Ljubicic J, Rutishauser D, Schmid M, Weiss T, Zhang Q, Sun R, Wang B, Yi X, Wu Z, Gao H, Cai X, Ruan G, Zhu T, Xu C, Lou S, Yu X, Gillet L, Blattmann P, Saba K, Fankhauser C, Guo T. High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification. Mol Oncol 2019; 13:2305-2328.
18.09.2019High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification
18.09.2019Mol Oncol 2019; 13:2305-2328
Zhu Yi, Christiansen Ailsa, Fritz Christine, Rupp Niels J, Poyet Cédric, Rushing Elisabeth, Weller Michael, Roth Patrick, Haralambieva Eugenia, Hofer Silvia, Chen Chen, Jochum Wolfram, Gao Xiaofei, Teng Xiaodong, Chen Lirong, Zhong Qing, Wild Peter J, Aebersold Ruedi, Ljubicic Jelena, Rutishauser Dorothea, Schmid Michael, Weiss Tobias, Zhang Qiushi, Sun Rui, Wang Bo, Yi Xiao, Wu Zhicheng, Gao Huanhuan, Cai Xue, Ruan Guan, Zhu Tiansheng, Xu Chao, Lou Sai, Yu Xiaoyan, Gillet Ludovic, Blattmann Peter, Saba Karim, Fankhauser Christian D, Guo Tiannan
Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
Guo T, Aebersold R, Wild P, Poyet C, Saba K, Fankhauser C, Jochum W, Rueschoff J, Wagner U, Wong C, Charmpi K, Rupp N, Zhong Q, Li L, Beyer A. Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers. Life Sci Alliance 2018; 1
29.05.2018Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
29.05.2018Life Sci Alliance 2018; 1
Guo Tiannan, Aebersold Ruedi, Wild Peter J, Poyet Cédric, Saba Karim, Fankhauser Christian Daniel, Jochum Wolfram, Rueschoff Jan H, Wagner Ulrich, Wong Christine E, Charmpi Konstantina, Rupp Niels J, Zhong Qing, Li Li, Beyer Andreas
Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing
Zhong Q, Diebold J, McKee T, Jochum W, Kashofer K, Hofman P, Zischka M, Moch H, Rechsteiner M, Rogel U, Vassella E, Wagner U, Kurt H, Molinari F, Cathomas G, Komminoth P, Barman-Aksözen J, Schneider-Yin X, Rey J, Wild P. Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathol Res Pract 2018; 214:957-963.
22.05.2018Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing
22.05.2018Pathol Res Pract 2018; 214:957-963
Zhong Qing, Diebold Joachim, McKee Thomas, Jochum Wolfram, Kashofer Karl, Hofman Paul, Zischka Melanie, Moch Holger, Rechsteiner Markus, Rogel Uwe, Vassella Erik, Wagner Ulrich, Kurt Henriette, Molinari Francesca, Cathomas Gieri, Komminoth Paul, Barman-Aksözen Jasmin, Schneider-Yin Xiaoye, Rey Jean-Philippe, Wild Peter J
Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
Fankhauser C, Moch H, Sulser T, Poyet C, Hermanns T, Rueschoff J, Rupp N, Omlin A, Gillessen Sommer S, Schüffler P, Wild P. Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer. Oncotarget 2017; 9:10284-10293.
04.12.2017Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
04.12.2017Oncotarget 2017; 9:10284-10293
Fankhauser Christian D, Moch Holger, Sulser Tullio, Poyet Cédric, Hermanns Thomas, Rueschoff Jan H, Rupp Niels J, Omlin Aurelius, Gillessen Sommer Silke, Schüffler Peter J, Wild Peter J
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
Zhong Q, Poyet C, Blattner M, Soldini D, Moch H, Rubin M, Noske A, Rüschoff J, Haffner M, Jochum W, Perner S, Buhmann J, Rüschoff J, Guo T, Gabrani M, Schüffler P, Rechsteiner M, Liu Y, Fuchs T, Rupp N, Fankhauser C, Wild P. Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Sci Rep 2016; 6:24146.
07.04.2016Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
07.04.2016Sci Rep 2016; 6:24146
Zhong Qing, Poyet Cédric, Blattner Miriam, Soldini Davide, Moch Holger, Rubin Mark A, Noske Aurelia, Rüschoff Josef, Haffner Michael C, Jochum Wolfram, Perner Sven, Buhmann Joachim M, Rüschoff Jan H, Guo Tiannan, Gabrani Maria, Schüffler Peter J, Rechsteiner Markus, Liu Yansheng, Fuchs Thomas J, Rupp Niels J, Fankhauser Christian, Wild Peter J
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Templeton A, Schiess R, Wild P, Rüschoff J, Thalmann G, Dietrich P, Aebersold R, Klingbiel D, Gillessen Sommer S, Müller B, Winterhalder R, Stenner F, Dutoit V, Cathomas R, Rothermundt C, Bärtschi D, Dröge C, Gautschi O, Borner M, Fechter E, Swiss Group for Clinical Cancer Research (SAKK). Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). Eur Urol 2013; 64:150-8.
06.04.2013Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
06.04.2013Eur Urol 2013; 64:150-8
Templeton Arnoud, Schiess Ralph, Wild Peter J, Rüschoff Jan H, Thalmann George, Dietrich Pierre-Yves, Aebersold Ruedi, Klingbiel Dirk, Gillessen Sommer Silke, Müller Beat, Winterhalder Ralph, Stenner Frank, Dutoit Valérie, Cathomas Richard, Rothermundt Christian, Bärtschi Daniela, Dröge Cornelia, Gautschi Oliver, Borner Markus, Fechter Eva, Swiss Group for Clinical Cancer Research (SAKK)
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
Riener M, Moch H, Clavien P, Hellerbrand C, Jungbluth A, Jin B, Knuth A, Soll C, Wild P, Jochum W. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma. International journal of cancer. Journal international du cancer 2009; 124:352-7.
15.01.2009Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
15.01.2009International journal of cancer. Journal international du cancer 2009; 124:352-7
Riener Marc-Oliver, Moch Holger, Clavien Pierre-Alain, Hellerbrand Claus, Jungbluth Achim, Jin Boquan, Knuth Alexander, Soll Christopher, Wild Peter J, Jochum Wolfram